why not? the "debt" is paid..there is no dilution and
why not? the "debt" is paid..there is no dilution and hasn't been in months. Also, there is no further dilution to be considered. She made this point clear she will not be looking to toxic loans to finance her company. it was stated in a pr that she would be looking for alternative financing. Then realizing the pre purchase order she received gave her the funds to move forward so no further financing was needed.
So...that clears up the convertible note issue..
whatever matters are relating to the financial statements shouldn't be construed as negative. but people spin this to make it work for their agenda. remember. liiehole is full of flippers, and shorters. that is what the company is based around. pump and dumps. toxic debt and shorting into that. when you see that it makes everything clear.
Audits are not taken lightly if there is fruedulent intent by FINRA and SEC.
lastly if you are criminal you would provide evidence to hang yourself would you??
1
Bemax Inc. (BMXCD) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Neo Pepe Coin: Breaking Ground in the Cryptocurrency World Neo Pepe Coin ($NEOP), an emergent player in the cryptocurrency landscape, has been making waves as it progresses through multiple presale stages. This new digital currency is not only attracting crypto enthusiasts but also garnering interest from larger investors or 'whales' looking for promising opportunities. A...
Continue Reading
Upcoming Conference Call for Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) has recently announced an upcoming conference call dedicated to discussing its financial results for the first quarter of fiscal year 2025. This important event is set for a morning slot to ensure that all stakeholders can participate and gain insights into the company's performance. Details of...
Continue Reading
Modella AI's PathChat DX Achieves Breakthrough Device Designation BOSTON -- Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is excited to announce that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This remarkable recognition...
Continue Reading
Nicholas Wealth Announces New Distribution Rate for FIAX ETF Nicholas Wealth, a well-respected player in the actively managed income exchange-traded funds (ETFs) space, has revealed an exciting increase in the distribution rate for the Nicholas Fixed Income Alternative ETF (FIAX) to 8.04%. This significant change underscores their dedication to delivering strong returns...
Continue Reading
Understanding Total Voting Rights in Investment Firms Investors often seek clarity regarding their holdings, and a key aspect of this is understanding total voting rights and share capital. Recently, significant information was disclosed by Hargreave Hale AIM VCT PLC, and it’s worth exploring what this means. Company Overview Hargreave Hale AIM VCT PLC stands out in the...
Continue Reading